MarketPulse

Phase 3

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Zealand Pharma

Zealand Pharma's Petrelintide Shows Promise in Obesity Drug Race

Zealand Pharma reports positive Phase 2 data for petrelintide, achieving 10.7% weight loss versus 1.7% placebo with favorable safety profile.
RHHBYZLDPYobesityweight management
BenzingaBenzinga··Business Wire

Savara to Present MOLBREEVI Progress at Miami Life Sciences Conference

Clinical-stage biotech $SVRA will present at 2026 Citizens Life Sciences Conference, showcasing progress on its Phase 3 rare respiratory disease program.
SVRAclinical-stagebiopharmaceutical
BenzingaBenzinga··Vandana Singh

Eli Lilly's Retevmo Shows Significant Benefit in Early-Stage Lung Cancer Trial

Eli Lilly's Retevmo shows significant benefits in early-stage lung cancer, reducing recurrence risk in Phase 3 trial. Positive results may expand the drug's use beyond advanced-stage disease.
LLYclinical triallung cancer